Vigene Biosciences Appoints COO
Molly McGlaughlin brings 27 years of experience in biologics manufacturing and development.
Telomere-Preserving RNA Guided by DNA Repair Enzyme
Research headed by a team at the École Polytechnique Fédérale de Lausanne (EPFL), in Switzerland, generated new insights into how RNA…
Eli Lilly bets $135M on neuro biotech Disarm Therapeutics, with up to $1.2B to come
Eli Lilly bets $135M on neuro biotech Disarm Therapeutics, with up to $1.2B to come…
NIHR review identifies long-term effects of COVID-19
Review draws on experiences of patients and expert consensus
Blood Test Potentially Improves Glioma Diagnosis and Monitoring
The TERT gene mutations C228T and C250T are known to promote cancer growth and are present in more than 60% of all gliomas. Now…
After R&D tryout, Astellas opts to acquire bioelectronics maker Iota Biosciences in $304M deal
After R&D tryout, Astellas opts to acquire bioelectronics maker Iota Biosciences in $304M deal…
Roche signs deal with Dyno Therapeutics for gene therapy vectors
Dyno could receive up to $1.8bn in collaboration-associated payments